[1]
“Treatment-Related Toxicity in Combined-Modality Therapy for Intermediate-Risk Rectal Cancer”, Вопр. онкол., vol. 71, no. 5, p. OF-2245, Nov. 2025, doi: 10.37469/0507-3758-2025-71-5-OF-2245.